Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.960
+0.070 (2.42%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $131.45 million as of July 23, 2026. Its market cap has increased by 0.33% in one year.
Market Cap
131.45M
Enterprise Value
107.74M
1-Year Change
0.33%
Ranking
Category
Stock Price
$2.96
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $131.45M, a decrease of -7.23%. That is a compound annual growth rate of -2.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 131.45M | -19.86% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cue Biopharma | 140.54M |
| Connect Biopharma Holdings | 139.15M |
| Aardvark Therapeutics | 132.64M |
| ProMIS Neurosciences | 129.94M |
| Tiziana Life Sciences | 129.31M |
| enGene Therapeutics | 129.29M |
| Spruce Biosciences | 125.72M |
| Vivani Medical | 123.32M |